No Record Found
Sector
PharmaceuticalsOpen
₹156.2Prev. Close
₹156.14Turnover(Lac.)
₹365.65Day's High
₹158.7Day's Low
₹156.252 Week's High
₹190.9752 Week's Low
₹108.12Book Value
₹102.2Face Value
₹1Mkt Cap (₹ Cr.)
1,657.22P/E
23.39EPS
6.68Divi. Yield
0.3212 May 2025
12:00 AM
AGM
Announcement Date: 12 May, 2025
12 May 2025
12:00 AM
Dividend
Dividend Amount: 0.5
Record Date: 24 Jul, 2025
30 Sep 2025
12:00 AM
Board Meeting
Agenda : Audited Result
12 May 2025
12:00 AM
BookCloser
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 10.54 | 10.51 | 10.42 | 10.37 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,048.1 | 977.94 | 926.58 | 841.06 |
Net Worth | 1,058.64 | 988.45 | 937 | 851.43 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Revenue | 636.35 | 465.51 | 441.95 | 426.59 |
yoy growth (%) | 36.7 | 5.33 | 3.6 | 43.2 |
Raw materials | -343.94 | -253.3 | -236.72 | -225.14 |
As % of sales | 54.04 | 54.41 | 53.56 | 52.77 |
Employee costs | -65.05 | -58.6 | -44.02 | -33.84 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Profit before tax | 123.65 | 91.18 | 121.71 | 120.01 |
Depreciation | -13.84 | -13.76 | -8.83 | -5.74 |
Tax paid | -33.73 | -23.68 | -29.37 | -45.57 |
Working capital | 74.06 | 16.34 | 44.64 | -0.64 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.7 | 5.33 | 3.6 | 43.2 |
Op profit growth | 19.39 | -8.69 | 7.58 | 5.23 |
EBIT growth | 34.17 | -24.46 | 2.52 | 31.32 |
Net profit growth | 37.27 | -26.89 | 24.04 | 30.55 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 809.73 | 770.24 | 751.59 | 747.45 | 577.21 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 809.73 | 770.24 | 751.59 | 747.45 | 577.21 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 36.49 | 28.74 | 17.79 | 31.49 | 20.22 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,655 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,540.1 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,602.4 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,446.6 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Vibha G Sharma
Whole-time Director
Shruti Vishal Rao
Non Executive & Independent Director
Santosh Parab
Company Sec. & Compli. Officer
Aditi Bhatt
Non Executive & Independent Director
Shilpa Bhatia
Managing Director
Gagan Harsh Sharmma
Chairman & Independent Director
Nandkumar Kashinath Chodankar
102 Hyde Park Sakivihar Road,
Andheri East,
Maharashtra - 400072
Tel: 91-22-42160000
Website: http://www.blissgvs.com
Email: cs@blissgvs.com; info@blissgvs.com
21 Shakil Niwas,
Mahakali Caves Road, Andheri (E),
Mumbai - 400 093
Tel: 91-22-28262920
Website: www.unisec.in
Email: info@unisec.in
Summary
Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Lim...
Read More
Reports by Bliss GVS Pharma Ltd
What is the Bliss GVS Pharma Ltd share price today?
What is the Market Cap of Bliss GVS Pharma Ltd?
What is the PE and PB ratio of Bliss GVS Pharma Ltd?
What is the 52 Week High and Low of Bliss GVS Pharma Ltd?
What is the CAGR of Bliss GVS Pharma Ltd?
What is the shareholding pattern of Bliss GVS Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.